Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon acquired 10 shares of Johnson Matthey stock in a transaction dated Wednesday, November 11th. The shares were bought at an average cost of GBX 2,433 per share, with a total value of £243.30.
Liam Condon also recently made the following trade(s):
- On Friday, September 11th, Liam Condon acquired 10,951 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,306 per share, with a total value of £252,530.06.
Johnson Matthey Stock Up 1.2%
Shares of Johnson Matthey stock traded up GBX 28 during trading on Wednesday, reaching GBX 2,428. 275,418 shares of the company traded hands, compared to its average volume of 1,903,049. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. Johnson Matthey PLC has a 1-year low of GBX 2,192 and a 1-year high of GBX 3,245.33. The company has a 50 day moving average price of GBX 2,382.13 and a 200-day moving average price of GBX 2,155.77. The firm has a market capitalization of £3.01 billion, a PE ratio of -31.84, a P/E/G ratio of 49,242.50 and a beta of 0.88.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the company. Jefferies Financial Group restated a “buy” rating and issued a GBX 2,330 target price on shares of Johnson Matthey in a research note on Tuesday, August 4th. Berenberg Bank increased their price target on Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,370.
Read Our Latest Research Report on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- Can Constellation Energy’s Contracts Power a Stock Rebound?
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
